MPG.eBooks - Search Results

61

Social cost-benefit analysis of air pollution control measures - Advancing environmental-economic assessment methods to evaluate industrial point emission sources

by van der Kamp, Jonathan
Published 2017

KIT Scientific Publishing

Subjects: “...cost-benefit analysis...”

Read Now

62

An overview of research on the effects of results-based financing

by Oxman, Andy, Fretheim, Atle
Published 2008

Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH)

Subjects: “...Cost-Benefit Analysis...”

Read Now

63

Challenges of Pharmacoeconomics in Global Health Arena

by Jakovljevic, Michael
Published 2019

Frontiers Media SA

Subjects: “...Costs...”

Read Now

64

Hearing aids for adults : benefits and costs

by Arlinger, S.
Published 2003

Swedish Council on Health Technology Assessment (SBU)

Subjects: “...Cost-Benefit Analysis...”

Read Now

65

CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.

Published 2018

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

66

The Cost of Insanity in Nineteenth-Century Ireland : Public, Voluntary and Private Asylum Care

by Mauger, Alice
Published 2017

Springer Nature

Subjects: “...costs...”

Read Now

67

Pulsed electron avalanche knife (PEAK) PlasmaBlade versus traditional electrocautery for surgery : a review of clinical effectiveness and cost-effectiveness

by Peprah, Kwakye, Spry, Carolyn
Published 2019

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

68

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

69

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

70

CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

71

CADTH Canadian Drug Expert Committee recommendation: Eliglustat (Cerdelga -- Sanofi Genzyme) : indication: Type 1 Gaucher disease

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

72

CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...

Published 2018

CADTH

Subjects: “...Drug Costs...”

Read Now

73

Pharmacist-led interventions for tobacco smoking cessation : a review of clinical effectiveness and cost-effectiveness

by Brett, Kendra, Yeung, Shirley S. T., Ford, Caitlyn
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

74

Care continuity in a patient-centered medical home setting

by Perry, Rebecca J., McCall, Nancy, Wensky, Suzanne G., Haber, Susan G.
Published 2016

RTI Press

Subjects: “...Health Care Costs...”

Read Now

75

CADTH Canadian Drug Expert Committee recommendation: Netupitant/palonosetron (Akynzeo -- Purdue Pharma) : indication : chemotherapy-induced nausea and vomiting

Published 2018

CADTH

Subjects: “...Cost-Benefit Analysis...”

Read Now

76

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

77

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

78

Defining an optimal format for presenting research needs

by Trikalinos, Thomas A.
Published 2011

Agency for Healthcare Research and Quality

Subjects: “...Cost-Benefit Analysis...”

Read Now

79

In vitro fertilization as a medical treatment for male or female infertility

Published 1997

Minnesota Department of Health

Subjects: “...Cost-Benefit Analysis...”

Read Now

80

Costs and benefits of health information technology

Published 2006

Agency for Healthcare Research and Quality

Subjects: “...Cost-Benefit Analysis...”

Narrow Search